Thalidomide is a kind of medication called an immunomodulatory agent that promotes an immune response to help slow tumor growth. Thalidomide is used in the treatment of several different indications.

SparkCures ID 6
Developed By Celgene Corporation, a wholly owned subsidiary of Bristol Myers Squibb
Brand Name Thalomid®
Generic Name Thalidomide
Treatment Classifications

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Untreated / Newly Diagnosed Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)